L
Lee A. Hebert
Researcher at Ohio State University
Publications - 190
Citations - 15211
Lee A. Hebert is an academic researcher from Ohio State University. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 55, co-authored 190 publications receiving 13844 citations. Previous affiliations of Lee A. Hebert include Medical College of Wisconsin & University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Jan J. Weening,Vivette D. D'Agati,Melvin M. Schwartz,Surya V. Seshan,Charles E. Alpers,Gerald B. Appel,James E. Balow,Jan A. Bruijn,Terence Cook,Franco Ferrario,Agnes B. Fogo,Ellen M. Ginzler,Lee A. Hebert,Gary Hill,Prue Hill,J. Charles Jennette,Norella C T Kong,Philippe Lesavre,Michael D. Lockshin,Lai-Meng Looi,Hirofumi Makino,Luiz Antonio Ribeiro de Moura,Michio Nagata +22 more
TL;DR: The main advantages of the current revised classification is that it provides a clear and unequivocal description of the various lesions and classes of lupus nephritis, allowing a better standardization and lending a basis for further clinicopathologic studies.
Journal ArticleDOI
The classification of glomerulonephritis in systemic lupus erythematosus revisited
Jan J. Weening,Vivette D. D'Agati,Melvin M. Schwartz,Surya V. Seshan,Charles E. Alpers,Gerald B. Appel,James E. Balow,Jan A. Bruijn,Terence Cook,Franco Ferrario,Agnes B. Fogo,Ellen M. Ginzler,Lee A. Hebert,Gary Hill,Prue Hill,J. Charles Jennette,Norella C T Kong,Philippe Lesavre,Michael D. Lockshin,Lai-Meng Looi,Hirofumi Makino,Luiz Antonio Ribeiro de Moura,Michio Nagata +22 more
TL;DR: The main advantages of the current revised classification is that it provides a clear and unequivocal description of the various lesions and classes of lupus nephritis, allowing a better standardization and lending a basis for further clinicopathologic studies.
Journal ArticleDOI
Intensive blood-pressure control in hypertensive chronic kidney disease.
Lawrence J. Appel,Jackson T. Wright,Tom Greene,Lawrence Y. Agodoa,Brad C. Astor,George L. Bakris,William H. Cleveland,Jeanne Charleston,Gabriel Contreras,Marquetta Faulkner,Francis B. Gabbai,Jennifer J. Gassman,Lee A. Hebert,Kenneth Jamerson,Joel D. Kopple,John W. Kusek,James P. Lash,Janice P. Lea,Julia B. Lewis,Michael S. Lipkowitz,Shaul G. Massry,Edgar R. Miller,Keith C. Norris,Robert A. Phillips,Velvie A. Pogue,Otelio S. Randall,Stephen G. Rostand,Miroslaw Smogorzewski,Robert D. Toto,Xuelei Wang +29 more
TL;DR: Overall analyses, intensive blood-pressure control had no effect on kidney disease progression, however, there may be differential effects of intensiveBlood pressure control in patients with and those without baseline proteinuria, as well as according to the baseline level of proteinuria.
Journal ArticleDOI
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).
Garabed Eknoyan,Thomas H. Hostetter,Thomas H. Hostetter,George L. Bakris,George L. Bakris,Lee A. Hebert,Lee A. Hebert,Andrew S. Levey,Andrew S. Levey,Hans-Henrik Parving,Hans-Henrik Parving,Michael W. Steffes,Michael W. Steffes,Robert D. Toto,Robert D. Toto +14 more